Cumberland Pharmaceuticals (CPIX) FCF Margin Growth (3y) (2013 - 2026)
Cumberland Pharmaceuticals (CPIX) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 213.00 |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 2,102.00 |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 180.00 |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 1,592.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -291.00 |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | -2,476.00 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 1,604.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 117.16 Mn | 113.29 Mn | - | -240,403.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -240,403.00 |
| Mar 31, 2026 | 2,078.00 |
| Dec 31, 2025 | -4,154.00 |
| Sep 30, 2025 | -2,032.00 |
| Jun 30, 2025 | -1,375.00 |
| Mar 31, 2025 | 3,447.00 |
| Dec 31, 2024 | -2,314.00 |
| Sep 30, 2024 | 2,554.00 |
| Jun 30, 2024 | -3,840.00 |
| Mar 31, 2024 | -4,239.00 |
| Dec 31, 2023 | 272.00 |
| Sep 30, 2023 | -1,188.00 |
| Jun 30, 2023 | 3,266.00 |
| Mar 31, 2023 | -2,693.00 |
| Dec 31, 2022 | 3,321.00 |
| Sep 30, 2022 | 1,281.00 |
| Jun 30, 2022 | 230.00 |
| Mar 31, 2022 | 315.00 |
| Dec 31, 2021 | 4,925.00 |
| Sep 30, 2021 | -69.00 |